Peptide Sequence Designer
Design peptide sequences with activity-specific motifs, charge calculation, hydrophobicity prediction, and solubility estimation. Based on known structure-activity relationships for antimicrobial, antioxidant, hormone, enzyme inhibitor, and neuropeptide classes.
Sequence Designer
Activity Class Guidelines
Antimicrobial Peptides (AMPs)
- Net charge: +2 to +9 (lysine/arginine-rich)
- Hydrophobic moment: 0.4–0.6
- Amphipathic α-helix or β-sheet
- Length: 10–30 amino acids
- Avoid Met, Asn at protease sites
- Examples: magainin, defensin, LL-37
Antioxidant Peptides
- Aromatic residues (Trp, Tyr, Phe) for electron donation
- Hydrophobic residues for lipid peroxidation inhibition
- His for metal chelation
- Cys for direct radical scavenging
- Length: 5–20 amino acids
- Examples: glutathione, kephirin, lunasin
Hormone Analogs
- Receptor-binding pharmacophore (HFwR for melanocortin)
- D-amino acid substitution at protease sites
- Fatty acylation for albumin binding
- PEGylation for extended half-life
- Length: 5–44 amino acids (varies by hormone)
- Examples: semaglutide, bremelanotide, oxytocin
Enzyme Inhibitors
- Cleavage site mimicry (transition state analog)
- D-amino acids at P1 position
- N-methyl amide bonds at cleavage site
- Macrocycle for protease resistance
- Length: 4–12 amino acids
- Examples: BPTI, aprotinin, omapatrelat
Charge and Hydrophobicity Reference
| Amino Acid | Charge | Hydropathy | Classification |
|---|---|---|---|
| Lys (K) | +1 | -3.9 | Positive, hydrophilic |
| Arg (R) | +1 | -4.5 | Positive, hydrophilic |
| Asp (D) | -1 | -3.5 | Negative, hydrophilic |
| Glu (E) | -1 | -3.5 | Negative, hydrophilic |
| His (H) | +0.5 (pH 6) | -3.2 | Positive (histidine), polar |
| Leu (L) | 0 | 3.8 | Hydrophobic |
| Ile (I) | 0 | 4.5 | Hydrophobic |
| Val (V) | 0 | 4.2 | Hydrophobic |
| Trp (W) | 0 | -0.9 | Aromatic, hydrophobic |
| Tyr (Y) | 0 | -1.3 | Aromatic, polar |
| Cys (C) | 0 | 2.5 | Polar, reactive |
| Gly (G) | 0 | -0.4 | Small, flexible |
Frequently Asked Questions
How accurate are the generated sequences?
Generated sequences are based on known structure-activity relationships from published literature. They provide starting points for design but require experimental validation. Actual activity depends on additional factors including secondary structure, solubility, and target cell specificity.
Can I use these sequences directly in experiments?
Generated sequences should be treated as design suggestions. Before synthesis, verify that the sequence is novel (blast search), has no predicted toxicity, and meets solubility requirements. Experimental validation through minimum inhibitory concentration (MIC) assays, cell-based assays, or receptor binding studies is essential.
How is solubility estimated?
Solubility is estimated using the GRAVY (Grand Average of Hydropathy) index. GRAVY values below -0.4 indicate high solubility, -0.4 to 0 indicate moderate solubility, and above 0 indicate low solubility. Charge density and net charge also contribute to solubility predictions.